23.09.2011 • News

Enzon Pharmaceuticals To Cut Nearly Half Of Its Workforce

 

Enzon Pharmaceuticals Thursday announced a 48% reduction in employees to more closely align its resources with the company's research and development activities.

Results for the ongoing quarter would include a charge related to the workforce reduction.

The reduction in force will reduce the number of employees by approximately 48%, to a total of 47, effective June 2012.

Enzon expects the reduction in force to result in approximately $6.0 million in reduced annualized operating expenses once the plan is fully implemented by the second quarter of 2012.

The Piscataway, New Jersey-headquartered company also expects to incur a charge in the third quarter of 2011 of approximately $3.0 million related to the reduction.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read